Karyopharm Therapeutics Inc. - Common Stock (KPTI)

8.7500
+0.5200 (6.32%)
NASDAQ · Last Trade: Mar 12th, 3:30 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026